NCT06745583 2026-04-09
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Phase 2 Recruiting
Clinical Trials
6 trialsNCT05637801 2026-02-05
Hope
Cognito Therapeutics, Inc.
Phase NA Active not recruiting
NCT05504811 2025-12-24
FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease
Flint Rehabilitation Devices, LLC
Phase NA Completed
NCT06245031 2024-05-07
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Cognito Therapeutics, Inc.
Phase NA Enrolling by invitation
NCT03556280 2021-08-24
Overture
Cognito Therapeutics, Inc.
Phase NA Active not recruiting
NCT03661034 2021-08-24
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
Cognito Therapeutics, Inc.
Phase NA Unknown